
Sign up to save your podcasts
Or
This week on BioTech Nation, Luminary Therapeutics CEO Jeff Liter shares how his team is working to make advanced cell therapy easier to access and more affordable. Instead of using each patient’s own cells, they use healthy donor cells that are ready to go. This approach could help more people get treated for cancer and autoimmune diseases like lupus, with just a single dose.
4.1
2929 ratings
This week on BioTech Nation, Luminary Therapeutics CEO Jeff Liter shares how his team is working to make advanced cell therapy easier to access and more affordable. Instead of using each patient’s own cells, they use healthy donor cells that are ready to go. This approach could help more people get treated for cancer and autoimmune diseases like lupus, with just a single dose.
6,133 Listeners
4,238 Listeners
32,299 Listeners
3,481 Listeners
22,089 Listeners
2,174 Listeners
26,469 Listeners
3,369 Listeners
6,696 Listeners
9,272 Listeners
318 Listeners
29 Listeners
15,335 Listeners
3,365 Listeners
1,175 Listeners